Log in

NASDAQ:ABIOArca Biopharma Stock Price, Forecast & News

-0.11 (-1.20 %)
(As of 06/2/2020 04:00 PM ET)
Today's Range
Now: $9.09
50-Day Range
MA: $4.96
52-Week Range
Now: $9.09
Volume603,433 shs
Average Volume4.57 million shs
Market Capitalization$14.45 million
P/E RatioN/A
Dividend YieldN/A
ARCA biopharma, Inc. is a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate, Gencaro (bucindolol hydrochloride), is an investigational, pharmacologically unique beta-blocker and mild vasodilator, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). The company also engages in the development of a preclinical plan for AB171, a new chemical entity for the treatment of various cardiovascular indications, such as peripheral arterial disease and chronic HF. It has a collaboration agreement with Medtronic, Inc. for the support of GENETIC-AF Phase 2B clinical trials; and Laboratory Corporation of America to provide the companion diagnostic test and services to support GENETIC-AF trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostic substances
Current SymbolNASDAQ:ABIO



Sales & Book Value

Annual SalesN/A
Book Value$4.77 per share


Net Income$-5,480,000.00


Market Cap$14.45 million
Next Earnings Date8/6/2020 (Estimated)
OptionableNot Optionable

Receive ABIO News and Ratings via Email

Sign-up to receive the latest news and ratings for ABIO and its competitors with MarketBeat's FREE daily newsletter.

Arca Biopharma (NASDAQ:ABIO) Frequently Asked Questions

How has Arca Biopharma's stock been impacted by COVID-19 (Coronavirus)?

Arca Biopharma's stock was trading at $3.36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ABIO shares have increased by 170.5% and is now trading at $9.09. View which stocks have been most impacted by Coronavirus.

When is Arca Biopharma's next earnings date?

Arca Biopharma is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Arca Biopharma.

How were Arca Biopharma's earnings last quarter?

Arca Biopharma Inc (NASDAQ:ABIO) posted its earnings results on Wednesday, May, 6th. The biopharmaceutical company reported ($0.83) earnings per share for the quarter, beating analysts' consensus estimates of ($2.04) by $1.21. View Arca Biopharma's earnings history.

Has Arca Biopharma been receiving favorable news coverage?

Media coverage about ABIO stock has been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Arca Biopharma earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media stories about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutArca Biopharma.

Who are some of Arca Biopharma's key competitors?

What other stocks do shareholders of Arca Biopharma own?

Who are Arca Biopharma's key executives?

Arca Biopharma's management team includes the following people:
  • Dr. Michael R. Bristow, Co-Founder, Pres, CEO & Director (Age 74)
  • Mr. Thomas A. Keuer, Chief Operating Officer (Age 60)
  • Mr. Christopher D. Ozeroff, Sr. VP, Gen. Counsel & Sec. (Age 60)
  • Mr. Brian L. Selby, Chief Accounting Officer & VP of Fin. (Age 57)

What is Arca Biopharma's stock symbol?

Arca Biopharma trades on the NASDAQ under the ticker symbol "ABIO."

Who are Arca Biopharma's major shareholders?

Arca Biopharma's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (1.79%). View institutional ownership trends for Arca Biopharma.

Which institutional investors are buying Arca Biopharma stock?

ABIO stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC. View insider buying and selling activity for Arca Biopharma.

How do I buy shares of Arca Biopharma?

Shares of ABIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Arca Biopharma's stock price today?

One share of ABIO stock can currently be purchased for approximately $9.09.

How big of a company is Arca Biopharma?

Arca Biopharma has a market capitalization of $14.45 million. Arca Biopharma employs 15 workers across the globe.

What is Arca Biopharma's official website?

The official website for Arca Biopharma is arcabio.com.

How can I contact Arca Biopharma?

Arca Biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The biopharmaceutical company can be reached via phone at 720-940-2100 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.